💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
|
🏷️ 产品编码
RB9T37014597
|
🧬 中文名称
Vanucizumab ELISA试剂盒(靶标:)
|
|
📝 英文名称
Vanucizumab ELISA Kit
| |
|
🔬 应用
ELISA
| |
|
🔢 登录号
P15692 & O15123
|
🔹 检测方法
Colorimetric
|
|
🔹 灵敏度
0.156 μg/ml
|
🔹 检测范围
0.31-5 μg/mL
|
|
🔹 回收率
80-120%
|
🔹 样本类型
Plasma, Serum
|
|
🔹 检测类型
Quantitative
|
🔹 背景信息
Vanucizumab (RG7221) is an experimental humanized monoclonal antibody (mAb) designed for the treatment of cancer. Vanucizumab is a bi-specific mAb composed of two different heavy chains and two different light chains. One arm of the antibody binds Angiopoietin-2 (Ang2) and the other is based on bevacizumab (Avastin), binding vascular endothelial growth factor A (VEGF-A). The antibody is designed to inhibit both VEGF-A and Ang2 simultaneously to offer superior clinical benefit compared to VEGF-A inhibition alone. This drug was developed by Genentech/Roche. On 12 Mar 2018, Roche completes a phase I trial in solid tumors (combination therapy, late-stage disease, metastatic disease, second-line therapy or greater) in Spain, France, and Belgium.
|
|
🏷️ 别名
RG-7221, RG7221, RO5520985, 1448221-05-3
| |
❄️ 稳定性和储存
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
🚚 运输条件
2-8 ℃
⚠️ For Research Use Only.